Ienna T M, McKenzie D C
School of Human Kinetics, University of British Columbia, Vancouver, Canada.
Int J Sports Med. 1997 Feb;18(2):142-8. doi: 10.1055/s-2007-972610.
To determine whether asthmatic athletes have normal physiological responses to exercise without pre-exercise medication, we studied 17 female and male asthmatic subjects, 9 highly trained (HT) and 8 moderately trained (MT) under 2 conditions: salbutamol (S) 200 micrograms taken via inhaler 15 minutes prior to exercise or placebo (PL). The exercise task was 4 continuous 5 minute increments representing 25, 50, 75 and 90% of the subject's VO2max.VO2, minute ventilation (VE), respiratory exchange ratio (RER), % saturation (SaO2), and HR were continuously measured during exercise. Blood lactate (LA) was measured each minute throughout exercise and recovery. Post-medication, exercise, and recovery measurements of peak expiratory flow rates (PEFR) were made using a Mini-Wright flow meter. No differences (p > 0.05) between treatment conditions were found at any stage of exercise with respect to VO2, VE, RER, HR and SaO2. However, among the HT group the mean HR for the 4 exercise conditions was significantly higher under PL (PL = 151.7;S = 147.2; p = 0.01). No difference was found in LA during exercise or in recovery. Pre-exercise PEFR was significantly higher when pretreatment was S(S = 582; PL = 545 l.sec-1; p = 0.003). During the exercise and recovery conditions mean PEFR measures were significantly higher (S = 600.1; PL = 569.6; p = 0.002) with the S treatment. Bonferroni's test detected a difference in PEFR measures between S and PL at 25% and 50% VO2max and 3 and 15 minutes into recovery. There was no difference in the physiological response to exercise between groups based on training status. It was concluded that although S affects the PEFR these asthmatic athletes do not have altered metabolic or ventilatory responses during this incremental exercise protocol.
为了确定哮喘运动员在无运动前用药情况下对运动是否有正常的生理反应,我们研究了17名哮喘受试者,其中9名是高度训练的(HT),8名是中度训练的(MT),在两种情况下进行研究:运动前15分钟通过吸入器吸入200微克沙丁胺醇(S)或安慰剂(PL)。运动任务是连续4次5分钟的递增,分别代表受试者最大摄氧量(VO2max)的25%、50%、75%和90%。在运动过程中持续测量VO2、分钟通气量(VE)、呼吸交换率(RER)、血氧饱和度(SaO2)和心率(HR)。在整个运动和恢复过程中每分钟测量血乳酸(LA)。用药后、运动中和运动后,使用小型赖特流量计测量呼气峰值流速(PEFR)。在运动的任何阶段,就VO2、VE、RER、HR和SaO2而言,治疗条件之间均未发现差异(p>0.05)。然而,在HT组中,4种运动条件下的平均心率在PL组显著更高(PL = 151.7;S = 147.2;p = 0.01)。运动期间或恢复过程中LA没有差异。预处理为S时运动前PEFR显著更高(S = 582;PL = 545升·秒-1;p = 0.003)。在运动和恢复条件下,S治疗的平均PEFR测量值显著更高(S = 600.1;PL = 569.6;p = 0.002)。Bonferroni检验在VO2max的25%和50%以及恢复的3分钟和15分钟时检测到S和PL之间PEFR测量值存在差异。基于训练状态,两组之间运动的生理反应没有差异。得出的结论是,虽然S会影响PEFR,但这些哮喘运动员在这种递增运动方案期间代谢或通气反应没有改变。